Health Innovation Spotlight: Brain Tumors
Channel: AZ Bio
Date: 06/06/2022

It is estimated that 700,000 Americans are living with a primary brain tumor and that an estimated 88,970 people will receive a primary brain tumor diagnosis this year.

GT Medical Technologies, Inc., is an Arizona company dedicated to improving the lives of patients with brain tumors.  Its GammaTile Therapy received FDA 510(k) regulatory clearance for the treatment of all types of recurrent brain tumors and newly diagnosed malignant tumors. 

A surgeon implants these 3D, resorbable collagen tiles that are embedded with radiation sources during the last five minutes of brain tumor removal surgery.  This helps to eliminate residual tumor cells that can cause the tumor to grow back.   This "one and done" procedure is a big win for patients and for their doctors too.  

This Sonoran Living Health Innovation Spotlight as paid for by AZBio.

Learn more about Arizona-based health innovations at https://www.azbio.org.azadvances